Table 3

In vitro cytokine-stimulated cell expansion from sorted KLS cells

Cytokine cocktailWT KLS, fold expansionGab2−/− KLS, fold expansionWT expansion/Gab2−/− expansion
IL-36S 831 ± 156 355 ± 190* 2.3 
IL-3SFT 675 ± 142 279 ± 122* 2.4 
IL-3S 506 ± 169 168 ± 110 3.0 
IL-3F 150 ± 104 25 ± 19 6.0 
IL-3T 50 ± 35 16 ± 14 3.1 
SFT 157 ± 37 14 ± 4* 11.1 
Cytokine cocktailWT KLS, fold expansionGab2−/− KLS, fold expansionWT expansion/Gab2−/− expansion
IL-36S 831 ± 156 355 ± 190* 2.3 
IL-3SFT 675 ± 142 279 ± 122* 2.4 
IL-3S 506 ± 169 168 ± 110 3.0 
IL-3F 150 ± 104 25 ± 19 6.0 
IL-3T 50 ± 35 16 ± 14 3.1 
SFT 157 ± 37 14 ± 4* 11.1 

IL-3 indicates murine IL-3 (20 ng/mL); 6, human IL-6 (50 ng/mL); S, murine stem cell factor (50 ng/mL); F, murine flt-3 ligand (50 ng/mL); and T, murine thrombopoietin (50 ng/mL). KLS cells were sorted by FACS and plated in 96-well plates in the presence of various cytokine cocktails. After 6 days in culture, the total nucleated cell count was determined using a hemacytometer. The fold cell expansion was calculated based on the starting number of cells seeded per well. The results are the averages plus or minus standard deviation for 3 experiments.

*P < .05 relative to wild-type KLS (WT KLS).

Close Modal

or Create an Account

Close Modal
Close Modal